𝔖 Bobbio Scriptorium
✦   LIBER   ✦

973 Metabolic Profile of Cisplatin-resistant Phenotype – Studies in Ovarian Carcinoma Cell Lines

✍ Scribed by M. Montopoli; D. Catanzaro; M. Bellanda; C. Giordano; S. Mammi; E. Ragazzi; L. Caparrotta

Book ID
117663423
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
55 KB
Volume
48
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative cytotoxicity of CI-973, cisp
Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines
✍ R. P. Perez; P. J. O'Dwyer; L. M. Handel; R. F. Ozols; T. C. Hamilton 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

## Abstract The clinical efficacy of cisplatin‐based chemotherapy for ovarian cancer is frequently compromised by drug resistance or dose‐limiting renal and neurologic toxicities. CI‐973 (NK‐121), a 2‐methyl‐1, 4‐butanediamine analogue of carboplatin, has shown little nephro‐and neuro‐toxicity in p

Radiotherapy as a cisplatin-sensitizer i
Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line
✍ David F. Silver; Clifford R. Wheeless Jr.; Norman H. Dubin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

## BACKGROUND. Stage 111 ovarian carcinoma has shown resistance to adjuvant chemotherapy following surgical cytoreduction. With recurrence of ovarian carcinoma, cell lines may develop resistance to previously used chemotherapy. This contributes to the fact that survival rates for patients with ova

Increased accumulation of p53 protein in
Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
✍ Robert Brown; Carol Clugston; Angela Edlin; Paul Vasey; Stanley B. Kaye; Philip 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 942 KB

## Abstract We have examined p53 protein levels in cell lines selected for resistance to the chemotherapeutic drug __cis__‐diamminedichloroplatinum (II), cisplatin. The majority of the independent cisplatin‐resistant clones isolated by a single selection with cisplatin from the ovarian tumour cell